FOXM1 and prostate carcinoma: Increased expression of FOXM1 is identified in multiple human cancers, including ovarian cancer, breast cancer, prostate cancer, hepatocellular carcinoma, colorectal cancer, melanoma, lung cancer, and gastric cancer, which indicates a poor prognosis in most solid tumors.